Loading clinical trials...
Loading clinical trials...
A Randomised Control Trial of the Use of an Intraarticular Hydrogel Arthrosemid® vs. Steroid for the Non-operative Management of Moderate to Severe Osteoarthritis
Conditions
Interventions
Arthrosamid® 2.5% iPAAG injectable implant
Steroid Drug
Locations
1
Ireland
Cappagh National Orthopaedic Hospital
Dublin, Dublin, Ireland
Start Date
March 1, 2026
Primary Completion Date
September 1, 2027
Completion Date
September 1, 2027
Last Updated
March 27, 2026
NCT06755697
NCT07551245
NCT06702046
NCT07225829
NCT06118892
NCT07153471
Lead Sponsor
Cappagh National Orthopaedic Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions